Vienna School of Clinical Research

VSCR is ISPOR Dubai 2018 partner and supports as exhibitor and with sponsorship.
https://vscr.at/en/healthcare-decision-making-in-the-middle-east-and-north-africa-role-of-heor-hta/

Healthcare Decision-Making in the Middle East and North Africa: Role of HEOR & HTA - VSCR

Lifelong learning is required to stay up to date on the complex field of Health Ecomomy and Health Outcome Research.
Our CEO Heinrich Klech wrote an article about the quality standards needed in education for professionals:
https://vscr.at/en/continued-professional-development-the-key-to-excellence/

Continued Professional Development - The Key to Excellence - VSCR VSCR promotes lifelong learning and complies with enhanced European quality standards in education and training for discovery, development and commercialization of medicines

Dávid Dankó, PhD, expert in health care management and Speaker at VSCR's Health Outcome Research programme in November, sheds some light on the early adaption of HTA in central European states and the development of the current situation:
👉https://vscr.at/the-evolution-of-hta-in-central-europe-opening-for-broader-considerations/

The Evolution of HTA in Central Europe: Opening for Broader Considerations? - VSCR Some Central European EU member states were relatively early adopters of health technology assessment (HTA) in the mid-2000’s.

Innovation in health care technologies needs a smart way for market access. Keith Tolley (Tolley Health Economics Ltd.) and Max Lebmeier (Athena Market Access Solutions Ltd.) are writing about the importance of HTA in processes of reimbursement.

https://vscr.at/attracting-investors-the-value-of-hta/

Attracting Investors - The Value of HTA - VSCR Much innovation in new health care technologies comes from small and medium biotech and pharma companies, with many recent advances in the areas of rare diseases such as muscular dystrophy, and gene therapies for retinal disorders.